Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0H4TP
|
||||
Former ID |
DNC002343
|
||||
Drug Name |
GSK189254A
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cognitive disorders [ICD9: 290-294, 294.0, 780.09, 780.9, 780.93; ICD10:F01-F07, F04, F05, R41.3] | Investigative | [536039] | ||
Company |
GlaxoSmithKline
|
||||
Structure |
Download2D MOL |
||||
Formula |
C21H25N3O2
|
||||
Canonical SMILES |
CNC(=O)C1=CN=C(C=C1)OC2=CC3=C(CCN(CC3)C4CCC4)C=C2
|
||||
InChI |
1S/C21H25N3O2/c1-22-21(25)17-6-8-20(23-14-17)26-19-7-5-15-9-11-24(18-3-2-4-18)12-10-16(15)13-19/h5-8,13-14,18H,2-4,9-12H2,1H3,(H,22,25)
|
||||
InChIKey |
WROHEWWOCPRMIA-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Histamine H3 receptor | Target Info | Antagonist | [536039] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.